Rheumnow

From Pain to Wellness in PsA  Secukinumab vs Ustekinumab in PsA  Izokibep: still enthused about enthesitis?  Using Digital Apps to Modify Pain in axSpA

"ROC-SpA Study"  Secukinumab vs Ustekinumab in PsA  RA ILD Prediction: simple as a dipstick?  Sjogren's Disease: PROs as a Filter for Precision Medicine  Why do patients stay in clinical trials?  Using Digital Apps to Modify Pain in axSpA  IgG4: Rare but Treatable! 

From Pain to Wellness in PsA  IL-2 Therapy in SLE? Maybe  Sexual Function in axSpA  "Fact or Fiction: Trinetics Research at ACR"  CD1/BCMA Dual Targeting: One too many targets in SLE  Hydroxychloroquine Blood Levels  The Great Debate: AI in Rheumatology  Coping Strategies in axSpA  "What to do After First TNR Failure in axSpA" 

Join panelists Drs. Brian Jaros, Akhil Sood and Michael Putman as they recap highlights from Day 4, the final day of the 2025 ACR Convergence meeting in Chicago.

Join RheumNow Faculty Drs. Shelia Reyes, Mike Putman,  Bella Mehta, and Jack Cush as they discuss highlights and key takeaways from the Day 3 Recap, at the 2025 ACR Convergence meeting in Chicago.

Screen RA ILD Properly  Rheumatoid Arthritis Highlights  Predicting Rheumatoid Arthritis  GDF-15: How Depression is Related to Lung Disease in RA 

"Leftover Pain in Inflammatory Arthritis"  Another Specialized Biomarker in PsA  Secrets and Pearls in Rheumatology  What's the latest in PsA?   

GDF-15: How Depression is Related to Lung Disease in RA  What Can we do About Chronic Pain?  What's the latest in PsA?  What to do after first TNR failure in axSpA? 

Secrets and Pearls in Rheumatology  Addressing Lupus Nephritis Timely  Fake Rheum Diagnostic Dilemmas  Rheumatoid Arthritis Highlights  Restoring B Cell Compartments with CAR T: Molecular Data is Here  Predicting Rheumatoid Arthritis h What Causes Infection in Vasculitis?  Is it All About the Weight Loss? Izokibep: still enthused about enthesitis?   T Cell Engagers: Are we engaged?  Fiber and Methotrexate 

Spondyloarthritis: The CLASSIC Study  "Leftover Pain in Inflammatory Arthritis"  NeuroImmune Modulation in RA: Results of the RESET RA Trial  Change it or Keep it? TNF in Axial SpA  Perspectives on CAR T Therapy  Addressing Lupus Nephritis Early  Addressing Lupus Nephritis Aggressively  CAR-T: The Future  Biomarker Discovery in axSpA  Another Specialized Biomarker in PsA  Revised Classification Criteria in axSpA 

Catching AxSpA Early: Closing the Diagnostic Gap  Early Peripheral SpA: Is it okay to stop treatment sometimes?  Difficult to Manage axSpA  Tofacitinib in AxSpA in Developing Countries  Late-Breaking Trials in axSpA and PsA  Durability and Safety of Bimekizumab  Biologics Improve Sexual Function in axSpA  Multidimensional Pain inventory in Axial SpA  Spondyloarthritis: The CLASSIC Study  Change it or Keep it? TNF in Axial SpA  "Leftover Pain in Inflammatory Arthritis" 

B Cell Depletion: Check the Lymph Node  "Next Generation T-Cell Engager: The Future"  Off the Shelf: CAR-T  Combining CAR-T with CAR-Treg All in One  CAR-T Therapy: Where is it Heading?  Safety of CAR-T  New Paradigms in RA Treatment  Perspectives on CAR T Therapy 

Wired for Success: Vagal Nerve Therapy in RA  RA: Does upfront TNFi save heartache?  New Paradigms in RA Treatment 

SLGT-2 and GLP-1 in RA: More than Weight Loss  ACR2025 Day 1 RECAP 

Cellular Biomarkers of Rheumatoid Arthritis  Day 2 Recap: ACR Convergence 2025 Highlights

STOP RA Cellular & Serologic Predictors  Rheumatoid Arthritis: Inject the Steroids  Is Low Disease Activity Low Enough? 

Catching PsA before it Starts  Day 2 Recap: ACR Convergence 2025 Highlights 

PsA and Brain Fog  GLP-1 Receptor Agonists in PsA: Mortality and MACE  PsA Predictors  When the Back Hurts: uncovering BASDAI drivers in PsA The Upper Hand in PsA? Not the Dominant One

Diagnostic Delays in PsA: A Radiographic Perspective  Late-Breaking Trials in axSpA and PsA  New Approaches to Therapy in PsA 

Psoriatic Arthritis Imaging  Specialized Biomarkers in PsA  PsA: Impact of Sex  GLP-1 and SGLT-2: Treatments Too Good to Ignore?